(S1 (S (S (NP (NN IL-17F) (NN deficiency)) (VP (VBZ inhibits) (NP (NP (JJ small) (JJ intestinal) (NN tumorigenesis)) (PP (IN in) (NP (JJ ApcMin/+) (NNS mice)))))) (. .)))
(S1 (S (S (NP (NN IL-17)) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NN gut) (NN homeostasis))))) (. .)))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN IL-17F))) (PP (IN in) (NP (JJ intestinal) (NN tumorigenesis)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN addressed))))) (. .)))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN ablation)) (PP (IN of) (NP (NN IL-17F)))) (ADVP (RB significantly)) (VP (VBZ inhibits) (NP (NP (JJ spontaneous) (JJ intestinal) (NN tumorigenesis)) (PP (IN in) (NP (NP (DT the) (JJ small) (NN intestine)) (PP (IN of) (NP (JJ Apc-LRB-Min/+-RRB-) (NNS mice))))))))))) (. .)))
(S1 (S (S (NP (NN IL-17F) (NN ablation)) (VP (VBD decreased) (NP (NP (NP (NP (NN IL-1beta)) (CC and) (NP (NN Cox-2))) (NN expression)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NP (NP (NN IL-17) (NN receptor) (NN C)) (PRN (-LRB- -LRB-) (NP (NN IL-17RC)) (-RRB- -RRB-))) (NN expression)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN increased) (PP (IN in) (NP (NP (NNS tumors)) (PP (IN from) (NP (JJ Apc-LRB-Min/+-RRB-) (NNS mice))))))))))))) (. .)))
(S1 (S (S (NP (NP (NN Lack)) (PP (IN of) (NP (NN IL-17F)))) (VP (VP (VBD did) (RB not) (VP (VB reverse) (NP (DT the) (NN splenomegaly)))) (CC but) (VP (ADVP (RB partially)) (VBD restored) (NP (JJ thymic) (NN atrophy))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT a) (JJ local) (NN effect)) (PP (IN of) (NP (NN IL-17F))) (PP (IN in) (NP (DT the) (NN intestine)))))))) (. .)))
(S1 (S (S (NP (ADJP (NN IL-17F) (JJ deficient)) (NN Apc-LRB-Min/+-RRB-) (NNS mice)) (VP (VBD showed) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (NP (JJ immune) (NN cell) (NN infiltration)) (PP (IN in) (NP (DT the) (NN lamina) (NN propria)))))))) (. .)))
(S1 (S (S (ADVP (RB Interestingly)) (, ,) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN IL-17A)) (PP (IN from) (NP (NN CD4) (NN T) (NNS cells))))) (PP (IN in) (NP (DT the) (NN lamina) (NN propria)))) (VP (VBZ remains) (ADJP (JJ unchanged) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN IL-17F)))))))) (. .)))
(S1 (S (ADVP (RB Collectively)) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBP suggest) (NP (NP (DT the) (ADJP (ADJP (JJ proinflammatory)) (CC and) (ADJP (JJ essential))) (NN role)) (PP (IN of) (NP (NN IL-17F))) (S (VP (TO to) (VP (VB develop) (NP (NP (JJ spontaneous) (JJ intestinal) (NN tumorigenesis)) (PP (IN in) (NP (JJ Apc-LRB-Min/+-RRB-) (NNS mice)))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN IL-17A)))))))))) (. .)))
